新天药业：8月21日召开董事会会议

Group 1 - The core point of the article is that Xintian Pharmaceutical announced a board meeting to discuss capital increase and equity transfer related to its affiliated company [1] - For the first half of 2025, Xintian Pharmaceutical's revenue composition shows that main business revenue accounts for 99.9%, while other business revenue accounts for 0.1% [1] - As of the report date, Xintian Pharmaceutical has a market capitalization of 3.1 billion yuan [1]